Unresectable endocrine mucin-producing sweat gland carcinoma revealing an actionable somatic CHEK2 gene mutation

• S. Tzoumpa,
• C. Béjar,
• B. Villette,
• B. Louveau,
• L. Zelek,
• A. Martin,
• O. Briard,
• D. Bitout,
• F. Caux,
• M. Battistella,
• S. Mourah,
• E. Maubec

Affiliations

S. Tzoumpa

Department of Dermatology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France

C. Béjar

Department of Dermatology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France

B. Villette

Department of Dermatology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France

B. Louveau

Department of Tumor Genomics and Pharmacology, Saint-Louis University Hospital, AP-HP, Paris-Cité University, Paris, France

L. Zelek

Department of Medical Oncology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France

A. Martin

Department of Pathology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France

O. Briard

Radiotherapy Institute of Bobigny – IRHE, Bobigny, France

D. Bitout

Department of Dermatology, Delafontaine Hospital, Saint-Denis, France

F. Caux

Department of Dermatology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France

M. Battistella

Department of Pathology, Saint-Louis University Hospital, AP-HP, Paris-Cité University, Paris, France; INSERM, UMR-S 976, Paris, France

S. Mourah

Department of Tumor Genomics and Pharmacology, Saint-Louis University Hospital, AP-HP, Paris-Cité University, Paris, France

E. Maubec

Department of Dermatology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France; INSERM UMR1124, Campus Saint-Germain-des-Prés, Université Paris Cité, Paris, France